Evidence updated August 6, 2026. Concordia Men's Health currently lists medication-only Compounded Semaglutide at $299 for a monthly plan, $849 for three months prepaid, or $1,599 for six months prepaid. The prepaid totals work out to $283.00 and $266.50 per month, respectively, but they are prepaid purchases—not monthly installment prices.
Those figures answer one specific cash-price question. They do not describe every semaglutide product, every seller, an insurance benefit, or a guaranteed treatment path. Concordia's offering is compounded semaglutide, not Wegovy, Ozempic, Rybelsus, or an FDA-approved generic. Compounded drugs are not FDA-approved. A licensed provider must review the private assessment and decide whether treatment and any prescription are appropriate.
Current CMH compounded semaglutide cash prices
| Medication-only term | Current price | Effective monthly amount | How to read it |
|---|---|---|---|
| Monthly | $299 | $299.00 | One monthly plan price. |
| Three months prepaid | $849 | $283.00 | The full three-month amount is prepaid after the required provider decision; fulfillment remains monthly. |
| Six months prepaid | $1,599 | $266.50 | The full six-month amount is prepaid after the required provider decision; fulfillment remains monthly. |
The effective monthly figures are arithmetic comparison tools: $849 divided by three and $1,599 divided by six. They are not separate installment offers. The selected checkout disclosure controls the amount due, authorization, capture, renewal, cancellation path, taxes, allocations, and other purchase terms.
Prices and commercial terms can change. Confirm the current offer at the time of purchase rather than treating an older search result, screenshot, social post, or cached page as a quote.
Why “semaglutide cost” is not one number
Semaglutide is an active ingredient, not a complete price identity. A cost statement is incomplete until it names the exact product or preparation and the exact commercial route. FDA-approved branded products, compounded preparations, care-program bundles, and medication-only plans are different categories with different evidence and terms.
The FDA explains that compounded drugs are not FDA-approved and are not FDA-approved generic drugs. FDA does not verify compounded drugs for safety, effectiveness, or quality before they are marketed. The agency also describes concerns with unapproved GLP-1 drugs used for weight loss. A lower or higher price cannot erase that regulatory-category difference.
That is why the CMH prices above must not be presented as the cash price of Wegovy or another FDA-approved semaglutide product. They belong only to CMH's current medication-only Compounded Semaglutide path. For a broader product-category comparison, read the semaglutide-versus-tirzepatide product-truth guide.
Use a five-line Price Identity Card
Before comparing two cash prices, write down these five lines for each offer. This Price Identity Card is an editorial comparison tool, not a clinical checklist, quality score, insurance estimate, or treatment selector.
- Exact product or preparation: identify the brand or compounded preparation, not only the ingredient.
- Regulatory category: state whether it is an FDA-approved product, a compounded preparation, or another unapproved category.
- Payment cadence: separate a monthly charge from a three- or six-month prepaid total.
- Included commercial scope: name what the displayed price includes and excludes without implying clinical approval.
- Renewal and refund boundary: record when renewal can occur and which shipped, unshipped, started, or unused components follow which rule.
The card prevents a common comparison error: putting an ingredient-only headline from one offer beside an all-in program price from another and calling the cheaper number the winner. The complete impression matters. The FTC Health Products Compliance Guidance explains that objective health claims require appropriate support and that qualifications must be considered as part of the full message. The same discipline helps with price claims: headline, product identity, term, inclusions, qualifications, links, and checkout should tell one consistent story.
What the medication-only price does—and does not—describe
CMH's current source-controlled offer describes the medication-only plan as a separate path from the 90-Day Momentum Program. Medication-only pricing must not be substituted for Momentum pricing, and medication-only customers must not be told that they receive the full Sprint structure or its services.
For the medication-only path, current CMH materials describe a provider-reviewed process with medication when prescribed, monthly pharmacy fulfillment for prepaid terms, supplies and shipping under the current arrangement, secure clinical messaging, and nonclinical administrative support. The exact selected checkout terms and current public policies control. Review the Terms & Conditions, Refund Policy, and FAQ together rather than relying on the price table alone.
The price does not prove medical eligibility, provider approval, a prescription, medication availability, a particular dose, uninterrupted fulfillment, continued treatment, insurance reimbursement, or a result. It also does not make CMH the clinical decision-maker. The provider-review guide explains that a licensed provider owns the individual decision.
Prepaid price is different from monthly fulfillment
A prepaid term answers “how much is paid for the selected period?” Monthly fulfillment answers “how is medication dispensed across that period when treatment continues?” Those are different questions.
Current CMH terms state that a card may be authorized at checkout and that the actual charge occurs only after provider review, approval, and prescription where required. For a prepaid medication-only term, fulfillment continues monthly. A prepaid purchase does not guarantee medication, dose, or continuation for the whole term. Clinical decisions remain with the licensed provider, and dispensing remains subject to the applicable pharmacy process.
When comparing plans, do not turn the effective monthly arithmetic into a fictional monthly payment. Record both the total cash commitment and the fulfillment cadence.
Refund and renewal terms belong in the cost comparison
A price comparison is incomplete if it ignores what happens after purchase. CMH's current public Refund Policy distinguishes medication accepted by the carrier from medication allocations that have not shipped. It also describes separate rules for medication-only prepaid plans and the Momentum Program. The exact checkout allocations and order confirmation govern the calculation.
Current terms also describe automatic renewal for selected plans unless renewal is canceled before processing. Canceling a future renewal and requesting a current-term refund are not the same action. Read the current checkout disclosure and policies before authorizing a purchase, and use the published cancellation route for commercial questions. Do not put symptoms, diagnoses, medication details, or other medical information in an ordinary cancellation or support message.
Does “without insurance” mean insurance is irrelevant?
No. It means this article is answering a cash-price question, not predicting benefits. Insurance coverage, reimbursement, deductibles, prior authorization, employer benefits, manufacturer programs, and pharmacy claims can differ by person, plan, product, and time. CMH does not promise that an insurer will cover or reimburse its compounded semaglutide offering.
If you compare a CMH cash price with an insured or manufacturer-supported price elsewhere, keep the categories visible. Compare the exact product, out-of-pocket amount, eligibility rules, term, included services, fulfillment route, renewal, and refund conditions. Do not compare CMH's compounded cash price with an approved-product list price as if the products or evidence were interchangeable.
Questions to answer before relying on a semaglutide price
- What exact product or compounded preparation does this price identify?
- Is the figure monthly, prepaid, an effective monthly calculation, or a temporary promotion?
- What amount is actually authorized and charged, and when?
- What services, supplies, shipping, or membership components are included or excluded?
- Does the offer keep medication-only care separate from a larger program bundle?
- What renews automatically, and what is the cancellation deadline and method?
- How are shipped and unshipped medication allocations treated?
- Which licensed provider makes the individual decision?
- Which approval, prescription, supply, continuation, reimbursement, or result is not guaranteed?
For current CMH medication-only Compounded Semaglutide, the cash figures are $299 monthly, $849 for three months prepaid, and $1,599 for six months prepaid as of August 6, 2026. The useful comparison does not stop at those numbers. Keep the exact compounded category, full prepaid commitment, monthly fulfillment, provider authority, current checkout terms, renewal, and refund boundary attached to the price.
Review the current CMH overview and public policies for the current commercial route. The direct assessment link is omitted here because its automated first-step check remains blocked; this article does not reinterpret or clear that separate route defect.
This article is general education and commercial-term explanation, not medical, insurance, tax, financial, or legal advice. It does not determine eligibility, recommend or select treatment, provide dosing or interaction guidance, predict coverage, or replace current checkout terms, complete product information, and a licensed provider's judgment.